ReShape^® Integrated Dual Balloon Featured in International Business Times

FDA Approves Treating Obesity With Nonsurgical Balloons

Adding another option to the existing list of weight-loss methods, the U.S. Food and Drug Administration (FDA) has approved the use of a unique balloon system to treat obesity. In this type of weight-loss treatment, a set of two inflatable balloons fills up the empty space in the patient’s stomach.

The ReShape Integrated Dual Balloon System hopes to help obese Americans who have tried a number of other weight-loss methods before. The new technique works by inserting the dual balloon into the empty stomach of the patient with the help of an endoscope.

To read the full story on IBTimes.com, click here.

Wall Street Journal Announces ReShape^® FDA Approval

ReShape^® is Now FDA Approved in the United States

A Review of Unmet Needs in Obesity Management